Though a significant number of lung cancer during pregnancy are associated with targetable genomic alterations such as ALK rearrangements (112), animal studies report post-implantation embryo loss, reduced fetal weight and congenital anomalies with multiple TKIs, hence their use remains contraindicated during pregnancy (113). The gene discussed is ALK; the disease is lung cancer.